OA08099A - Compositions et procédé pour protéger les lymphocytes T contre l'agent étiologique des lymphadénopathies et du syndrome d'immunodépression acquise. - Google Patents
Compositions et procédé pour protéger les lymphocytes T contre l'agent étiologique des lymphadénopathies et du syndrome d'immunodépression acquise.Info
- Publication number
- OA08099A OA08099A OA58679A OA58679A OA08099A OA 08099 A OA08099 A OA 08099A OA 58679 A OA58679 A OA 58679A OA 58679 A OA58679 A OA 58679A OA 08099 A OA08099 A OA 08099A
- Authority
- OA
- OAPI
- Prior art keywords
- lymphadenopathies
- protecting
- compositions
- lymphocytes against
- etiologic agent
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 210000001744 T-lymphocyte Anatomy 0.000 title abstract 2
- 206010062016 Immunosuppression Diseases 0.000 title 1
- 208000008771 Lymphadenopathy Diseases 0.000 title 1
- 230000001506 immunosuppresive effect Effects 0.000 title 1
- 208000011580 syndromic disease Diseases 0.000 title 1
- 241000700605 Viruses Species 0.000 abstract 1
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2812—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- External Artificial Organs (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8414172A FR2570278B1 (fr) | 1984-09-14 | 1984-09-14 | Compositions et procede pour proteger les lymphocytes t contre l'agent etiologique des lymphadenopathies et du syndrome d'immunodepression acquise |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA08099A true OA08099A (fr) | 1987-03-31 |
Family
ID=9307750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA58679A OA08099A (fr) | 1984-09-14 | 1985-09-16 | Compositions et procédé pour protéger les lymphocytes T contre l'agent étiologique des lymphadénopathies et du syndrome d'immunodépression acquise. |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0176429B1 (de) |
| JP (2) | JP2783403B2 (de) |
| AT (1) | ATE58478T1 (de) |
| CA (1) | CA1273304A (de) |
| DE (2) | DE3583400D1 (de) |
| ES (1) | ES8608884A1 (de) |
| FR (1) | FR2570278B1 (de) |
| OA (1) | OA08099A (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2592893A1 (fr) * | 1986-01-15 | 1987-07-17 | Pasteur Institut | Population de lymphocytes t4 specifiques du virus lav, leur procede d'obtention et leur application a la production de ce virus. |
| IL83687A (en) * | 1987-08-30 | 1995-03-30 | Yeda Res & Dev | Pharmaceutical compositions comprising molecular decays and their use in the manufacture of said compositions |
| WO1989004672A1 (en) * | 1987-11-20 | 1989-06-01 | The Upjohn Company | Derivatives of lincosaminide antibiotics |
| DE3784080T2 (de) * | 1987-12-19 | 1993-05-27 | Ao Forschungsinst | Antivirales therapeutikum. |
| DE3828582A1 (de) * | 1988-08-23 | 1990-03-01 | Max Planck Gesellschaft | Monoklonaler antikoerper zur inhibierung der infektion von zellen durch hiv-viren |
| EP0408372A1 (de) * | 1989-07-13 | 1991-01-16 | Smithkline Beecham Corporation | Antivirale Therapie |
| US5591448A (en) * | 1994-11-21 | 1997-01-07 | Tepic; Slobodan | Anti-viral therapeutic composition |
| CN106075626B (zh) * | 2016-07-01 | 2018-06-26 | 浙江大学 | 一种艾滋病血液净化治疗仪 |
| CN106166313B (zh) * | 2016-07-01 | 2018-09-07 | 浙江大学 | 一种艾滋病孕妇血液净化器 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4381295A (en) * | 1979-04-26 | 1983-04-26 | Ortho Pharmaceutical Corporation | Monoclonal antibody to human helper T cells and methods of preparing same |
| FR2504010B1 (fr) * | 1981-04-15 | 1985-10-25 | Sanofi Sa | Medicaments anticancereux contenant la chaine a de la ricine associee a un anticorps antimelanome et procede pour leur preparation |
-
1984
- 1984-09-14 FR FR8414172A patent/FR2570278B1/fr not_active Expired
-
1985
- 1985-09-13 DE DE8989108697T patent/DE3583400D1/de not_active Expired - Lifetime
- 1985-09-13 CA CA000490731A patent/CA1273304A/fr not_active Expired - Lifetime
- 1985-09-13 AT AT85401780T patent/ATE58478T1/de not_active IP Right Cessation
- 1985-09-13 ES ES546974A patent/ES8608884A1/es not_active Expired
- 1985-09-13 DE DE8585401780T patent/DE3580639D1/de not_active Expired - Lifetime
- 1985-09-13 EP EP85401780A patent/EP0176429B1/de not_active Expired - Lifetime
- 1985-09-13 JP JP60203239A patent/JP2783403B2/ja not_active Expired - Lifetime
- 1985-09-16 OA OA58679A patent/OA08099A/xx unknown
-
1996
- 1996-05-30 JP JP8137176A patent/JPH0912462A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| FR2570278B1 (fr) | 1987-02-13 |
| ATE58478T1 (de) | 1990-12-15 |
| ES546974A0 (es) | 1986-09-01 |
| EP0176429A1 (de) | 1986-04-02 |
| DE3583400D1 (de) | 1991-08-08 |
| ES8608884A1 (es) | 1986-09-01 |
| CA1273304A (fr) | 1990-08-28 |
| JPH0912462A (ja) | 1997-01-14 |
| EP0176429B1 (de) | 1990-11-22 |
| FR2570278A1 (fr) | 1986-03-21 |
| DE3580639D1 (de) | 1991-01-03 |
| JPS61143328A (ja) | 1986-07-01 |
| JP2783403B2 (ja) | 1998-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA199800357A1 (ru) | Фармацевтические ангиостатические дипептидные композиции и способы их применения | |
| BG91270A (bg) | Антивирусно и антибактериално средство и метод за използването му | |
| PT80303B (pt) | Processo para a preparacao de composicoes para a higiene bucal | |
| EP0219876A3 (en) | Antihypertensive agents comprising 2-alkynyladenosines as active ingredients | |
| AU561016B2 (en) | N-glycosylated carboxamide derivatives | |
| KR960701049A (ko) | 헤테로사이클릭 화합물, 이의 제조방법 및 이의 용도(Heterocyclic compounds and their preparation and use) | |
| IL99145A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
| DK0544714T3 (da) | Heterocycliske forbindelser og fremstilling og anvendelse deraf | |
| ES8506729A1 (es) | Un procedimiento para preparar nuevos compuestos de cefem | |
| OA08099A (fr) | Compositions et procédé pour protéger les lymphocytes T contre l'agent étiologique des lymphadénopathies et du syndrome d'immunodépression acquise. | |
| OA07525A (fr) | Dérivés d'acides-animés, leur préparation et utilisation ainsi que les compositions contenant ces dérivés. | |
| NZ222045A (en) | From diamides up to tetrapeptides for use as anticanvulsants | |
| ES2016464A6 (es) | Procedimiento para preparar derivados de 2', 5' -oligoadenilato. | |
| OA07270A (fr) | Dérivés N-(vinblastinoyl-23) d'acide aminés, leur préparation et leur application thérapeutique. | |
| ATE22282T1 (de) | Pentacycloundecan derivate, verfahren zu ihrer herstellung, und diese enthaltende pharmazeutische zusammensetzungen. | |
| FR2701952B1 (fr) | Nouveaux dérivés cyclopeptidiques de l'angiopeptine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. | |
| EP0335426A3 (en) | Compositions and process for protecting t lymphocytes against the etiological agent of lymphadenopathy and acquired immunodepression syndrom | |
| IT8221552A0 (it) | Nuovi composti ad attivita'antineoplastica, procedimetno per la loro preparazione e relative composizioni farmaceutiche. | |
| IE810008L (en) | Iodinated propionitrile | |
| IT1198378B (it) | Composti idrossiminici e alcossiminici ad attivita' calcioanatagonista,procedimento per la loro preparazione e relative composizioni farmaceutiche | |
| DE3885978D1 (de) | Cephemverbindungen und Verfahren zu ihrer Herstellung. | |
| IT8219176A0 (it) | Composti ad attivita' nootropa,anti astenica e antiulcera,processo per la loro preparazione e relative composizioni farmaceutiche | |
| IT8320672A0 (it) | Nuovi composti ad attivita'antineoplastica, procedimento per la loro preparazione e relative composizioni farmaceutiche. | |
| PH16820A (en) | 1-methyl-2-(3'-sulphamyl-4'-chlorobenzamido)-isoindoline,a process for its preparation and therapeutic compositions which contain it as active principle | |
| IT1222140B (it) | Composti ad attivita' antivirale,procedimento per la loro preparazione e relative composizioni farmaceutiche |